Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

When we think of heart-related emergencies, we often picture heart attacks or strokes. But there’s another silent yet life-threatening condition that gets very little attention- aortic aneurysm.

Aortic valve stenosis is the most prevalent heart valve disease worldwide. Although interventional treatment options have rapidly improved in recent years, symptomatic aortic valve stenosis is still ...

Objective Bicuspid aortic valve (BAV) is associated with early valvular dysfunction and proximal aorta dilation with high heterogeneity. This study aimed to assess the determinants of these ...

An Ohio State spinoff has raised $5 million to speed already fast-growing sales of its AI-powered software for heart surgeons ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

The cellular mechanisms responsible for aortic aneurysm formation constitute a complex, orchestrated series of events that result in dramatic pathological changes in the anatomy and function of the ...

Case 1: A Patient with Small Aortic Annulus and Low Coronary Arteries Take-Off Presenter: Pier Pasquale Leone More slides + Advertisement ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Notably, new permanent pacemakers (PPMs) stayed at 17.8% for both Navitors, but in those without baseline conduction defects, the figure dropped to 12.3% for Navitor Vision versus ...